Gyre Therapeutics Inc (GYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,501 | 37,070 | 40,402 | 36,491 | 15,045 |
| Marketable Securities | 12,307 | 15,355 | 19,647 | 17,874 | 14,846 |
| Receivables | 22,993 | 31,308 | 26,107 | 24,859 | 20,380 |
| Inventories | 11,352 | 10,171 | 8,854 | 8,861 | 7,878 |
| Other current assets | 3,817 | 5,638 | 3,566 | 499 | 2,138 |
| TOTAL | $91,732 | $102,369 | $98,576 | $91,285 | $68,448 |
| Non-Current Assets | |||||
| PPE Net | 23,572 | 23,599 | 23,608 | 23,401 | 23,518 |
| Investments And Advances | 29,419 | 23,516 | 20,317 | 21,528 | 21,367 |
| Intangibles | 4,627 | 4,727 | 4,847 | 4,962 | 5,083 |
| Other Non-Current Assets | 12,665 | 11,921 | 12,036 | 11,470 | 11,374 |
| TOTAL | $70,283 | $63,763 | $60,808 | $61,361 | $61,342 |
| Total Assets | $162,015 | $166,132 | $159,384 | $152,646 | $129,790 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 491 | 351 | 784 | 290 | 350 |
| Accrued Expenses | 15,415 | 14,359 | 11,799 | 14,924 | 17,239 |
| Other current liabilities | N/A | N/A | 58 | N/A | 28 |
| TOTAL | $19,788 | $18,286 | $15,913 | $16,920 | $18,991 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,409 | 5,207 | 3,730 | 5,149 | 5,461 |
| TOTAL | $5,242 | $5,564 | $6,056 | $6,283 | $6,497 |
| Total Liabilities | $25,030 | $23,850 | $21,969 | $23,203 | $25,488 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 97,028 | 96,964 | 96,333 | 96,313 | 93,758 |
| Common Shares | 91 | 91 | 91 | 91 | 87 |
| Retained earnings | -77,667 | -68,426 | -66,703 | -70,313 | -70,755 |
| Other shareholders' equity | 39,910 | 38,570 | 36,893 | 38,228 | 36,791 |
| TOTAL | $136,985 | $142,282 | $137,415 | $129,443 | $104,302 |
| Total Liabilities And Equity | $162,015 | $166,132 | $159,384 | $152,646 | $129,790 |